Computational analysis of multimorbidity between asthma, eczema and rhinitis

Abstract

BackgroundThe mechanisms explaining the co-existence of asthma, eczema and rhinitis (allergic multimorbidity) are largely unknown. We investigated the mechanisms underlying multimorbidity between three main allergic diseases at a molecular level by identifying the proteins and cellular processes that are common to them.MethodsAn in silico study based on computational analysis of the topology of the protein interaction network was performed in order to characterize the molecular mechanisms of multimorbidity of asthma, eczema and rhinitis. As a first step, proteins associated to either disease were identified using data mining approaches, and their overlap was calculated. Secondly, a functional interaction network was built, allowing to identify cellular pathways involved in allergic multimorbidity. Finally, a network-based algorithm generated a ranked list of newly predicted multimorbidity-associated proteins.ResultsAsthma, eczema and rhinitis shared a larger number of associated proteins than expected by chance, and their associated proteins exhibited a significant degree of interconnectedness in the interaction network. There were 15 pathways involved in the multimorbidity of asthma, eczema and rhinitis, including IL4 signaling and GATA3-related pathways. A number of proteins potentially associated to these multimorbidity processes were also obtained.ConclusionsThese results strongly support the existence of an allergic multimorbidity cluster between asthma, eczema and rhinitis, and suggest that type 2 signaling pathways represent a relevant multimorbidity mechanism of allergic diseases. Furthermore, we identified new candidates contributing to multimorbidity that may assist in identifying new targets for multimorbid allergic diseases.

Multimorbidity in Asthma, Allergic Conditions and COPD Increase Disease Severity, Drug Use and Costs: The Finnish Pharmacy Survey

“…Rhinitis is associated with both allergic and non-allergic asthma, but also a non-rhinitic asthma phenotype has been identified [19, 20]. Shared risk gene variants have been suggested in asthma, allergic rhinitis, and atopic eczema [21].…”

Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

“…The concept of asthma and rhinitis multimorbidity is now globally accepted in developed and developing countries. 51 It is now recognized that multimorbidity is independent of IgEmediated allergy, 8,52 and new phenotypes of severe airway disease have been identified. The implementation of the multimorbid concept in clinical practice has a direct benefit for the patient whose nasal symptoms are often more bothersome than asthma.…”

Atopy and allergic diseases among Saudi young adults: A cross-sectional study

“…Consistent with results from previous studies, the symptoms of BA, AR, and AD in our study were significantly associated with adults who had atopic disease, as compared with those who did not. 9,[31][32][33] Recent evidence suggests that asthma, rhinitis, and eczema are coexisting disorders that are becoming more prevalent among people with atopic disease; these disorders also occur together in individuals without atopic disease and are strongly associated with specific IgE antibodies. 9,34 In this study, 12% of participants with atopy had more than one allergic disease, and 1% had "atopic march".…”